EUVIMED · CrossrefJournal
Anti-Cancer Drugs
ISSN 0959-4973 · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Predictors of cervical lymphatic spread in papillary thyroid microcarcinoma: clinical and pathological determinants
Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report
Isovanillin regulates gastric cancer cells apoptosis and metastasis by targeting ROS-mediated MAPK and PI3K signaling pathways
Dauricine induces ferroptosis in neuroblastoma by inhibiting methyltransferase-like 1-mediated N7-methylguanosine methylation of solute carrier family 3 member 2
Clinical ethics in oncology
MLN4924 suppresses pancreatic cancer progression and enhances chemosensitivity to gemcitabine by targeting the PTGS2/EGFR–PI3K/Akt/mTOR signaling axis
Synergistic antitumor effect between Olaparib and Chidamide by regulation of MYBL2 in lung cancer
A novel HEAT repeat protein 5B anaplastic lymphoma kinase fusion in lung adenocarcinoma confers sensitivity to ensartinib
The novel integrin-linked kinase inhibitor nilotinib suppresses cancer progression by promoting ubiquitylation of autoimmune regulator in oesophageal squamous cell carcinoma
The future of cancer treatment: integrating science, technology, and global collaboration
Ubiquitination mediated cisplatin resistance in bladder cancer
Discovery of an orally active and liver-targeted dual prodrug of 5-fluoro-2′-deoxyuridine-5′-monophosphate for the treatment of hepatocellular carcinoma
Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report
Drug repurposing of liver cancer based on multimodal neural network and virtual screening
Envafolimab combined with chemotherapy in advanced thymic carcinoma – first clinical experience with a novel subcutaneous programmed death-ligand 1 inhibitor
Activation of the caspase-1/gasdermin D pathway via α-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth
Overcoming refractory leptomeningeal metastasis in nonsmall cell lung cancer with intrathecal pemetrexed and osimertinib: a case report
Early sensitivity and rapid resistance to drug therapy in primary pulmonary nuclear protein in testis carcinoma
Nivolumab- and ipilimumab-induced myositis, myasthenia gravis, and myocarditis in a patient with metastatic melanoma
A dual thermo/pH-sensitive hydrogel as 5-Fluorouracil carrier for breast cancer treatment
A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinib
Upregulation of CDC25B by transcription factor TEAD4 drives invasion and inhibits cisplatin sensitivity through cell adhesion in stomach adenocarcinoma
Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation
TRIM11 expression levels was downregulated and prevents ferroptosis of cardiomyocyte by Dusp6 in acute myocardial infarction
CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma
Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells
Early dose reduction of osimertinib in advanced EGFR-mutated non-small cell lung cancer
Targeting HSP47 for cancer treatment
HMOX1 regulates ferroptosis via mic14 and its impact on chemotherapy resistance in small-cell lung cancer
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma
Volumes
2026 · 752025 · 1112024 · 1292023 · 1442022 · 2442021 · 1422020 · 1472019 · 1442018 · 1232017 · 1362016 · 1342015 · 1322014 · 1412013 · 1272012 · 1362011 · 1402010 · 1262009 · 1392008 · 1322007 · 1522006 · 1592005 · 1492004 · 1322003 · 1322002 · 1372001 · 1502000 · 1171999 · 1301998 · 1211997 · 1551996 · 1751995 · 1501994 · 2571993 · 1081992 · 1091991 · 771990 · 34
EUVIMED